INTRODUCTION
γ-Aminobutyric acid (GABA) is considered to be a principal inhibitory neurotransmitter and GABAergic neurons comprise more than 30 % of all neurons in the adult mammalian central nervous system. Glutamic acid decarboxylase (EC 4.1.1.15 ; GAD) is the ratelimiting enzyme that catalyses the production of GABA from glutamic acid [1] . The two enzymes, GAD65 and GAD67, encoded by separate genes, have been found in mammalian brain [2, 3] . They can be distinguished by their molecular masses as well as by their cofactor interactions and subcellular distributions [4, 5] . GAD65 is largely membrane-bound and is relatively enriched in vesicular membranes, whereas GAD67 is soluble and is distributed in the cytoplasm. GAD67 cDNAs have been isolated from several species, including human [6] , rat [7] , mouse [8] and cat [9] . The amino acid sequence of GAD67 is highly conserved among these species. Mouse GAD67 (mGAD67) cDNA encodes a protein of 515 amino acids that is preceded by at least approx. 200 bp of 5h-untranslated region (5h-UTR) sequence [8] . Analysis of the partial genomic structure revealed the presence of an intron within the 5h-UTR [8] . The mGAD67 gene is located on chromosome 2 [10] .
GAD is expressed primarily in GABAergic neurons of the adult mammalian central nervous system, but it is also present in pancreatic β-cells and testis [11, 12] . During embryonic development, GAD67 is detectable at an early stage [13] . GAD67 expression is modulated by pharmacological treatment with drugs. Injection of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) into monkeys results in increases in GAD67 mRNA levels [14] . Agonists of dopamine D # receptors reduce GAD67 mRNA levels, whereas antagonists of D # recep-
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a single gene by alternative splicing using two different donor sites and a common acceptor. The exons were found 1n5 and 0n6 kb upstream of exon 1. The corresponding promoter regions of these exons have a number of putative regulatory elements, including Sp1-and Krox-24-binding sites. Analysis of mGAD67 transcripts demonstrated that each of the 5h-untranslated exons was expressed in mouse brain. In contrast, exon 0A, but not exon 0B, was expressed in mouse testis and pancreas. These results suggest that these transcripts may be regulated under the control of independent promoters. tors increase its levels in rat striatum [15] . Cyclic AMP decreases GAD67 expression in C6 cells [16] . Kainic acid-induced seizure results in a marked increase in GAD67 expression in rat hippocampal granule cells [17] .
We analysed mGAD67 cDNAs and identified a cDNA clone that differed from the previously determined mGAD67 sequence at the 5h-end of the clone. The two sequences diverged at the point where exon 0 is spliced on to exon 1. We have characterized exon\intron organization, alternative splicing products and 5h-flanking regions of the mGAD67 gene to investigate the regulatory mechanisms controlling transcription of this gene.
MATERIALS AND METHODS

Isolation and characterization of genomic clones
A mouse 129SV genomic library in the λFIXII vector (Stratagene, La Jolla, CA, U.S.A.) was screened by plaque hybridization using a 1n8 kb cloned fragment of mGAD67 cDNA as the probe. Nine overlapping plaques covering the region from exon 3 to the 3h-region were isolated. A 0n2 kb cloned fragment (corresponding to exon 0 and part of intron 0) was used to screen and identify the 5h-region. A recombinant phage clone λ105 extending from the 5h-flanking region to exon 1 was isolated. Another screening was performed using a SacI fragment of the λ105 clone (corresponding to intron 0 and exon 1) and a recombinant phage, λ141, extending from intron 0 to exon 4, was isolated. Positive plaques were purified, and DNA was isolated by the bacteriophage lysate method [18] . Six overlapping phages, λ2, λ5, λ23, λ27, λ105 and λ141, covering the whole gene, were subcloned in pBluescript SK(k) (Stratagene, La Jolla, CA, U.S.A.) using NotI or Sal I of the λFIXII polylinker and an internal NotI or Sal I site to create plasmids for further analysis.
Nucleotide sequence analysis
cDNA clones, genomic clones and PCR products were digested with restriction enzymes, subcloned into pBluescript SK(k) and sequenced by the dideoxy method [19] .
Preparation of RNA
Total cellular RNA was prepared from mouse brain, testis or pancreas by an established method [20] . Polyadenylated [poly(A) + ] RNA was prepared using Oligotex-dT30 (TaKaRa, Otsu, Japan).
Rapid amplification of 5h-cDNA ends ( 5h-RACE )
cDNA was synthesized from 1 µg of the mouse brain total RNA using Superscript reverse transcriptase (Life Technologies, Gaithersburg, MD, U.S.A.) and the primer GF1, 5h-ACAGAT-CTTCAGGCCCAGTT-3h, an antisense oligonucleotide corresponding to nucleotides j237 to j256 of mGAD67 cDNA [8] . After addition of a poly(C) tail with deoxynucleotidyl transferase (Life Technologies, Gaithersburg, MD, U.S.A.), the cDNA was amplified using 5h-CUACUACUACUAGGCCACGCGTCGA-CTAGTACGGGIIGGGIIGGGIIG-3h as anchor primer (Life Technologies) and the primer GF2, 5h-GCAGGTTGGTAGT-ATTAGGA-3h, which corresponds to nucleotides j166 to j185 of mGAD67 cDNA [8] . PCR was performed for 33 cycles of 1 min at 94 mC, 1 min at 60 mC and 2 min at 72 mC. PCR products were separated on a 2 % agarose gel, identified by Southern blotting and subcloned into the pBluescript SK(k) vector.
Reverse transcriptase PCR ( RT-PCR )
cDNA was synthesized using reverse transcriptase in a reaction mixture containing 1 µg of poly(A) + RNA from mouse brain, testis and pancreas. The equivalent of one fiftieth of the cDNA was then amplified using the GF1 primer from the mGAD67 common sequence and the other GF3 primer, which is specific to the exon 0A sequence (5h-AAGCAAGGAAGCAGCCCTG-3h corresponding to nucleotides j39 to j57 ; see Figure 4A ) or GF4, which is an exon 0B-specific primer (5h-ACTCTTCTATC-CGAGGTCTC-3h corresponding to nucleotides j18 to j37 ; see Figure 4B ). DNA was amplified using ExTaq polymerase (TakaRa, Otsu, Japan). The reactions were denatured at 94 mC for 1 min before undergoing 33 cycles of 30 s at 94 mC, 1 min at 58 mC and 2 min at 72 mC. PCR products were run on a 2 % agarose gel, transferred to nylon membranes and detected by hybridization to the GF2 oligonucleotide.
RESULTS AND DISCUSSION
Cloning and exon/intron junctions
Recombinant λ phages carrying the mGAD67 gene were isolated from a mouse genomic library. An analysis of the regions in six recombinant overlapping λ clones revealed that the coding region of the gene is spread over 45 kb. A complete restriction map of the clones was prepared for the restriction endonucleases BamHI, EcoRI, SacI and Sal I (Figure 1 ). The gene is divided into 19 exons (Figure 1) , and all nucleotide sequences flanking the exons (Table 1 ) match the eukaryotic 5h-donor and 3h-acceptor consensus splice junction sequence GT-AG [21, 22] . Compared with the structure of the human GAD67 gene, all of the exon\intron junctions are located at the same sites, except for exon 0B and exon F, which has not been described in humans [23] . The mGAD67 gene is a unique gene [10] which gives rise to mRNA variants generated by alternative splicing [24] . mGAD67 variants contained 80 or 86 bp and their expression is developmentally regulated ; they are preferentially expressed in foetal brain [24] . In the mGAD67 gene, these foetal mRNA variants are encoded by exons 5 and 6, and were named exon F ( Figure 1 and Table  2 ).
5h-Untranslated regions
The 5h-RACE method was used to analyse the 5h-ends of mGAD67 transcripts expressed in mouse brain. Several of the clones obtained using the 5h-RACE method had sequences identical to the one previously found in mGAD67 cDNA [8] . The remainder contained a novel form of the mGAD67 transcript, which diverged at the same point as other cDNAs, indicating that two different exons are alternatively spliced at this site. We nominated the 5h-sequence found in the published cDNA clone as exon 0A. The novel sequence obtained from the 5h-RACE clones was named exon 0B. The analysis of cloned λ phage genomic DNA revealed that exon 0A and exon 0B are located 1n5 kb and 0n6 kb upstream of exon 1, respectively (Figure 2 ).
There are a number of genes which have both alternative promoters and splicing in the 5h-UTR, including the genes for betaine γ-amino-n-butyric acid transporter [25] , aromatase cytochrome P-450 [26] and acetylcholinesterase [27] . It is probable 
Figure 2 Exon/intron structure and splice sites in the 5h-UTRs of the mouse GAD67 gene
Open boxes represent untranslated sequence, and filled boxes represent the coding region of the gene.
that these genes encode the same polypeptide product and differ only in their 5h-UTR sequences. Possible functions of the 5h-UTR include modulating mRNA degradation [28] and regulating translation [29, 30] . Therefore, the 5h-UTR of mGAD67 transcripts may be involved in regulating its translatability and\or stability.
Figure 3 Expression of the mouse GAD67 5h-exons in mouse brain and testis
RNA from mouse brain (lanes 1 and 5), testis (lanes 2 and 6) and pancreas (lanes 3 and 7) was reverse-transcribed and then amplified using a 5h-exon-specific primer and a primer for exon 2. The RT-PCR products were analysed by electrophoresis on a 2 % agarose gel. Lanes 1-4 contained a primer specific for exon 0A and lanes 5-8 contained the exon 0B-specific primer. PCR products were detected by hybridization to an internal oligonucleotide (GF2). Lanes 4 and 8 are negative controls containing no template.
Tissue-specific expression of 5h-exons
Expression of the alternative 5h-exons was analysed by RT-PCR in brain, testis and pancreas ( Figure 3 ). The mRNAs from brain, testis or pancreas were reverse-transcribed using an oligo(dT) primer. The cDNA was then amplified using the mGAD67 exon 2 primer and a primer specific for exon 0A or exon 0B. PCR products were detected by hybridization to an internal oligonucleotide. mGAD67 transcripts containing exon 0A were de-
Figure 4 5h-Exon and -flanking sequences of the mouse GAD67 gene
The 5h-flanking sequences of exons 0A (A) and 0B (B) are shown along with the exon sequences. The exons are underlined, and numbering begins at the major transcription start site for each exon. The asterisks indicate the position of the 5h-ends of 5h-RACE clones. Abbreviations : PEA3, PEA3-binding site ; Sp1, Sp1-binding site ; Krox-24, Krox-24-binding site ; C/EBP, binding sites for CCAAT-box-enhancer-binding protein ; F-ACT1, F-ACT1-binding site.
tected in brain, testis and pancreas. Exon 0B was detected only in brain, but transcripts containing exon 0B were not detected either in testis or in pancreas RNA. These results demonstrate that exon 0B was expressed in brain, and not in testis or pancreas, indicating that promoter B is activated in a tissuespecific manner. The majority of the 5h-RACE clones from brain contained the exon 0A sequence at their 5h-ends. These results suggest that the transcript containing exon 0A is the most abundant mGAD67 transcript in the tissues analysed. However, it remains to be determined which of these two 5h-exons represents the major transcript in other tissues, including spinal cord and foetal brain.
Analysis of 5h-flanking sequences
To aid the identification and characterization of the different promoters, we determined the nucleotide sequence of the 5h-flanking regions of each of the 5h exons (Figures 4 and 5) . We found that promoter A has a high GjC content (more than 70 %) in the 180 bp preceding the transcription start site.
Promoter A contains a non-canonical TATA box (TATAA) at position k170. However, it is likely that the TATA box may not be functional because of the existence of too many nucleotides between the TATA box and the transcription start site. Promoter A also contains a PEA3-binding site, an SP1-binding site and a Krox-24-binding site. Promoter B lacks a TATA box. However, it contains two Sp1-binding sites, a C\EBP-binding site and a PEA3-binding site. No CCAAT box was found in either promoter.
A sequence comparison between the promoter A region of mouse and human GAD67 [31] showed high similarity, suggesting the presence of similar regulatory elements for the expression of this gene ( Figure 5) . Interestingly, the position of the Krox-24-binding site in the mouse and human GAD67 gene promoter is conserved ( Figure 5 ). However, the former is identical to a classic Krox-24-binding site, whereas the latter has one mismatch from the canonical site of Krox-24 [32] . The Krox family factors, which contain zinc-finger motifs, are encoded by immediateearly genes which are induced by diverse signals, such as growth factors and mitogens [33] . Krox-24 transcripts are very abundant in the brain [34] . The aldolase C gene is specifically expressed in brain, and the promoter of this gene has two Krox-24-binding sites. Mutation of either Krox-24-binding site is sufficient to inactivate the gene, suggesting the Krox-24 factor may be involved in neuron-specific gene expression [35] .
Mouse P19 cells, a line of pluripotent embryonic carcinoma stem cells, can be induced to differentiate into neurons and glia by treatment with retinoic acid. mGAD67 expression increases along neuronal differentiation of P19 cells [36] . It has been reported that there is an increase in Krox-24 transcript levels during P19 cell differentiation [34] . Moreover, previous studies with gel-shift assays showed that Krox-24-binding activity in the mouse neurofilament light-chain gene promoter is in good agreement with the time course pattern of the appearance of Krox-24 transcripts during P19 cell differentiation [37] . These results indicate that Krox-24 may participate in the regulation of mGAD67 gene expression. Sp1 consensus elements bind a 100 kDa zinc-finger protein and confer basal activity on the promoters of viral or cellular genes [38] [39] [40] . Although originally associated with constitutive transcription, Sp1 can also co-operate with other transcription factors, such as NF-κB [41] and OTF-1 [42] . Figure 4(A) shows that an Sp1 site is close to the Krox-24 site in promoter A of the mGAD67 gene. It is tempting to speculate that co-operative interaction between Sp1 and Krox-24 might be involved in the regulation of the mGAD67 gene. Sp1 consensus motifs are found within the promoters of a number of neurally restricted genes [43, 44] , suggesting that the mGAD67 gene might be controlled by constitutive promoters whose activity is modulated by sequence-specific enhancer-and\or silencer-binding proteins to produce restricted patterns of expression. An F-ACT1-binding site was found in exon 0B ( Figure 4B ). F-ACT1 is a zinc-finger protein and is identical to a multifunctional transcription factor described as YY1 or NF-E1 [45] . It has been reported that four NF-E1 binding sites were present in the 5h-flanking region of an opioid receptor gene, KOR3, which is primarily expressed in brain [46] . Therefore, it is possible that F-ACT1 may be involved in brain-specific expression of exon 0B of the mGAD67 gene. The notion that these sequences might represent specific promoter motifs is being tested in transgenic mice.
Conclusions
The present characterization of the structural organization of the mouse GAD67 gene demonstrates the existence of multiple transcripts, which are generated by the alternative splicing of different 5h-exons on to a splice acceptor site within the 5h-UTR of the gene. The transcription of this gene thus appears to be under the control of alternative promoters that are activated in a tissue-specific manner which may play an important role in the regulation of the mGAD67 gene. The molecular and genetic mechanisms of phenotype selection of GABAergic synthesis and the maintenance of GABAergic function remain to be elucidated. Analysis of the expression mechanism of GAD genes will provide insights into the questions raised above. The assessment of GAD gene expression will await further studies in transgenic mice.
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